Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026918 (
Mycobacterium
)
52,428
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A
Mycobacterium
sp., strain
KR2
which was able to utilise pyrene as sole source of carbon and energy was isolated from a polycyclic aromatic hydrocarbon (PAH) contaminated soil originating from the area of a former gaswork plant. The isolate metabolised up to 60% of the pyrene added (0.5 mg/mL) within 8 days at 20 degrees C. Cis-4,5-pyrene dihydrodiol, 4,5-phenanthrene dicarboxylic acid, 1-hydroxy-2-naphthoic acid, 2-carboxybenzaldehyde, phthalic acid, and protocatechuic acid were identified as degradation products. Based on these findings a degradation pathway for pyrene is suggested which is in good accordance with the data published so far on bacterial pyrene metabolism.
...
PMID:Pyrene degradation by Mycobacterium sp. strain KR2. 973 74
With isotopic techniques, the effects of the concentration, ionic type, and straight chain length of surfactants on the degradation of phenanthrene by
Mycobacterium
ssp.
KR2
were studied. The results showed that in the presence of surfactants, the degradation of phenanthrene was not increased. It was delayed in high concentrations of surfactants (> or = 20 mg.L-1). Tween 80 in its low concentration (< or = 10 mg.L-1) was used as a preferential substrate utilized by
Mycobacterium
ssp.
KR2
. The degradation was affected by the ionic types of surfactants, and the inhibition to the phenanthrene degradation was cationic surfactant TDTMA > anionic surfactant LAS > nonionic surfactant Tween 80. Different lengths of surfactant straight chains had different influence on the degradation of phenanthrene.
...
PMID:[Effects of surfactants on degradation of phenanthrene by Mycobacterium ssp]. 1499 68
Polyketides are secondary metabolites of microorganisms synthesized by serialized reactions of a set of enzymes called polyketide synthases (PKS). As many infectious microorganisms are acquiring tolerance to antibiotics, the need for novel medicines is increasing. Recently, various methods are being used for drug discovery, including gene manipulation for biosynthesis of antibiotics such as polyketides. Due to their importance as drugs, the volume of data on polyketides is rapidly increasing. In the present paper, by using SEARCHPKS and ASMPKS servers, domain identification, and domain organization, substrate specificity of AT domain, domain assembly and chemical moiety of three Actinomycetes i.e.,
Mycobacterium
abscessus, Micromonospora chalcea and Streptomyces achromogenes are analyzed. So far, no secondary metabolite of any of these bacteria is known. Here, it was demonstrated that KR1,
KR2
and KR3 domains from M. chalcea, KR5 domain from M. abscessus and KR6 domain from S. achromogenes could be assigned as B1-type, while KR4 domain from M. abscessus and KR7 domain from S. achromogenes could be assigned as A1 type. Substrate specificity of AT1 and AT2 of M. abscessus predicted to be malonate. AT2 domain of PKS protein from S. achromogenes also selected as malonate. Methylmalonate substrate was predicted for AT1 and AT3 domains. All of the AT domains in modules of PKS protein of M. chalcea were predicted to be specific for methylmalonate. Analysis of folding rate of these proteins showed that the logarithm of (kf) decreased in proportion to protein chain length. We have also performed a comprehensive phylogenetics analysis of AT and DH domains with FabA, FabZ and dehydratase proteins of various bacteria and secondary metabolites. The phylogenetic tree derived from these sequences reflects the long joint evolution process.
...
PMID:Computational prediction of properties and analysis of molecular phylogenetics of polyketide synthases in three species of Actinomycetes. 2047 Feb 51